日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Temporal trends in progression risk in smoldering myeloma: a systematic review

冒烟型多发性骨髓瘤进展风险的时间趋势:系统评价

Ludwig, Heinz; Kastritis, Efstathios; Bernhard, Sarah; van de Donk, Niels W C J; Boccadoro, Mario; Terpos, Evangelos; Musto, Pellegrino; Sonneveld, Pieter; Mohyuddin, Ghulam Rehman

Why We Do Not Recommend That People With High-Risk Smoldering Myeloma Receive Treatment

为什么我们不建议高危冒烟型多发性骨髓瘤患者接受治疗

Mohyuddin, Ghulam Rehman; Lemieux, Mackenzie; Chakraborty, Rajshekhar; Gertz, Morie

In reply: Why selinexor remains a subpar option?

回复:为什么赛利尼索仍然不是最佳选择?

Mohyuddin, Ghulam Rehman; Meirson, Tomer

Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review

多发性骨髓瘤移植禁忌症定义不一致:一项系统性综述

Neupane, Karun; Singstock, Mitch; Shah, Darshi; Dahal, Riyasha; Mian, Hira; Smith, Febe; Chakraborty, Rajshekhar; Al Hadidi, Samer; Mainou, Maria; Grajales-Cruz, Ariel; Naqvi, Syeda Mahrukh Hussnain; Shain, Kenneth H; Goodman, Aaron; Costa, Luciano J; Qazilbash, Muzaffar; Mohyuddin, Ghulam Rehman

Elranatamab for Treatment of Multiple Myeloma With Central Nervous Involvement Refractory to Other Interventions

Elranatamab 用于治疗对其他干预措施无效的伴有中枢神经系统受累的多发性骨髓瘤

Julian, Kelley; Peterson, Briana; Mohyuddin, Ghulam Rehman

Oncology "Me-Too" Drugs Compared With Original Drugs in Randomized Clinical Trials

肿瘤“仿制药”与原研药在随机临床试验中的比较

Olivier, Timothée; Smith, Calvin; Prasad, Vinay; Mohyuddin, Ghulam Rehman

Real-world treatment patterns for teclistamab and talquetamab in multiple myeloma (MM): experience from 609 patients

teclistamab 和 talquetamab 在多发性骨髓瘤 (MM) 中的真实世界治疗模式:来自 609 例患者的经验

Chunara, Farheen; Lugo, Chris; Osinski, Kristen; Shah, Mansi R; Shah, Nishi; Kent, Jessica; Mohyuddin, Ghulam Rehman; Radhakrishnan, Sabarinath Venniyil; Kaur, Gurbakhash; Chakraborty, Rajshekhar; Banerjee, Rahul; Rasche, Leo; Schinke, Carolina; D'Souza, Anita; Szabo, Aniko; Mohan, Meera

Therapeutic anti-cancer vaccines: a systematic review of prospective intervention trials for common hematological malignancies

治疗性抗癌疫苗:常见血液系统恶性肿瘤前瞻性干预试验的系统评价

Shah, Darshi; Shah, Veer; Shah, Karan; Shah, Prachi J; Alsadhan, Muatassem; Haslam, Alyson; Prasad, Vinay; Qazilbash, Muzaffar H; Chakraborty, Rajshekhar; Mohyuddin, Ghulam Rehman

Comparing the clinical trial efficacy versus real-world effectiveness of treatments for multiple myeloma: a population-based study

比较多发性骨髓瘤治疗的临床试验疗效与真实世界疗效:一项基于人群的研究

Visram, Alissa; Chan, Kelvin Kar-Wing; Seow, Hsien; Pond, Gregory; Gayowsky, Anastasia; Mohyuddin, Ghulam Rehman; McCurdy, Arleigh; Sandhu, Irwindeep; Venner, Christopher; Lancman, Guido; Balitsky, Amaris; Kouroukis, Tom; Bruins, Robert; Kumar, Shaji; Fonseca, Rafael; Mian, Hira

Evaluating early intervention in smoldering myeloma clinical trials: a systematic review

评估早期干预在冒烟型多发性骨髓瘤临床试验中的应用:系统评价

Kakkilaya, Apoorva; Trando, Aaron; Cliff, Edward R Scheffer; Mian, Hira; Al Hadidi, Samer; Aziz, Muhammad; Goodman, Aaron M; Jeong, Ah-Reum; Smith, Wade L; Kelkar, Amar H; Russler-Germain, David A; Mehra, Nikita; Chakraborty, Rajshekhar; Gertz, Morie A; Mohyuddin, Ghulam Rehman